Ken Griffin's position in Recursion Pharmaceuticals is currently worth $12 Million. That's 0.01% of their equity portfolio (1079th largest holding). The first Recursion Pharmaceuticals trade was made in Q4 2021. Since then Ken Griffin bought shares seven more times and sold shares on five occasions. The investor's estimated purchase price is $23.6 Million, resulting in a loss of 49%.